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The 1978 Annuai Report of the International Joint Commission's Committee
on the Assessment of Human Health Effects of Great Lakes Water Quaiity was
prepared both for the Water Quaiity Board and for the Science Advisory Board.
Highiights from the activities of the Committee, from its inaugurai
meeting, eariy in 1978 to the present, are reported here.
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One of the most important recommendations contained in the Sixth Annual
Great Lakes Water Quality Report of the International Joint Commission (1978)
has urged that the Governments of the United States and Canada collaborate
and develop a program which establishes a running inventory of toxic chemicals
used, manufactured or imported into the Great Lakes Basin" and "evaluate their
risk to human health and the environment.
As a result of its continuing and
growing concern over the potential human health hazards of contaminants which
bioaccumulate in fish, a special committee on the Assessment of Human Health
Effects of Great Lakes Water Quality was formed in early 1978.

TERMS OF REFERENCE
In considering its mandate, the committee proposed and agreed to take the
following under its purview:
1.

Assess the risk to health posed by contaminants in the Great Lakes

2.

Review action levels and guidelines for selected substances.

3.

Provide to the International Joint Commission through its Boards,
interpretation and consultation on health matters.

4.

Maintain awareness of current advances and knowledge as they relate to
human health aspects of the ecosystem.

ecosystem.

The result of the inaugural meeting of this committee was a decision to
review the 1975 Water Quality Board's Appendix E, "Status Report on the
Persistent Toxic Substances in the Lake Ontario Basin." The compounds
selected for study initially were lead and mirex.
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The committee, at its October 1978 meeting, discussed the problem of
establishing criteria for rating the hazards presented by the 400 chemicals
recently identified in the Great Lakes by the Great Lakes Water Quality Board;
Appendix E, Status Report on Organic and
see Great Lakes Water Quality Board
Heavy Metal Contaminants in the Lakes Erie, Michigan, Huron and Superior

Basin, by D. Konasewich, N. Traversy, H. Zar, July 1978, Windsor, Ontario.

The 1978 Michigan Critical Materials Publication, published by the Office

of Toxic Materials Control, Michigan Department of Natural Resources, formed

the basis for committee review and discussion. The chemicals in the Michigan
document include those with well recognized high toxicity (e.g., PCBs,
mercury, cyanide), those obtained from various lists of priority chemicals
developed by NIOSH, U.S. EPA, etc., and chemicals of specific concern to

Michigan.

Michigan's review process utilizes a hazard assessment methodology which
considers acute and chronic toxicity, carcinogenicity, mutagenicity,
teratogenicity, persistence, bioaccumulation and aesthetics. Chemicals are
numerically scored as to their hazard and those posing a high environmental
concern (i.e., a high score) are included in the Critical Materials
Publication.

Table 9 -

Critical Materials Register Hazard Assessment Sheet,"

is reproduced below from the Michigan publication.

The Human Health Effects Committee selected the following categories:
-

-

I.

acute toxicity;
carcinogenicity;

reproductive;
heritable mutagenicity;
neurobehavioural toxicity; and
chronic adverse effects.

ACUTE TOXICITY
Criterion:

Score
4 Extremely Toxic

3 Highly Toxic

2 Moderately Toxic
1 Slightly Toxic
O Relatively Non-Toxic

Oral L050
<5 mg/kg

5-50 mg/kg

<50-500 mg/kg
<O.5-5 g/kg
<5 g/kg

* Insufficient information

Dermal L050
<5 mg/kg

5 200 mg/kg

<200 SOO mg/kg
<O.5-5 g/kg
<5 g/kg

Table 9.
Michigan
Critical Materials Register Hazard Assessment Sheet
Cannon Chemical Name
Chemical Abstract Name
I.

Score

Acute Toxicity

Chemical Abstract No.
V.

Score

Category

Score

[\MNv

mg/kg

DERMAL L050

mg/kg

AQUATIC 96 HOUR LDSO

C k

<5
<5
5-200
5-50
>50-500
>200-500
>500-5000
>500-5000
>5000
>5000
Insufficient Information

mg/l

<1
1-10
>10 100
>100-1000
>1000

3
2

1

0

*

Not carcinogenic

Insufficient Information

Score
NMNHO

on

Category
human suspect
Human positive
Animal positive
Animal suspect
Carcinogenic by a route other than oral or dermal
Strongly potential carcinogenic by accepted mutagenicity
screening tests or accepted cell transformation studies
Potential carcinogen by accepted mutagencity screening
tests or accepted cell transformation studies

Readily degradable

Bioaccumulation

VI.

II. Carcinogenicity
Score
7

Score

Insufficient Information

Teratogenicity
Score

Category

VIII.

Category
Fish Tainting/Tase and
Odor (Threshold level

0.0001-0.001
>0.001-0.01
>0.01-0.1
>0.1

Foaming, floating

film, and/or major

colour change

Yes

No

Chronic Adverse Effects

Scare
4

2
1

0*

[\MC)!

Confirmed
Suspect
Not teratogenic
Insufficient Information

>6.00
5.00-5.99
4.50-4.99
4.00-4.49
<4.00

O

IV.

>4000
1000-3999
700-999
300-699
<300
Insufficient Information

MNv

NVNOQ

Suspect - multicellular organisms
Insufficient Information

Log P

in water - mg/l)

Category
Confirmed

Suspect - micro-organisms
Not a hereditary mutagen

Bioaccumulation

Aesthetics

VII.

III. Hereditary Mutagenicity
Score

Category
Very persistent
Persistent
Slowly degradable
Moderately degradable

arrow «oi

ORAL L050

Persistence

Category
Irreversible effects
Reversible effects
Adverse effects by route other than oral, dermal,
or aquatic
No detectable adverse effects
Insufficient Information

Rationale:

Classification is based upon generally accepted terminology found in the
available literature on acute toxicity.
In review of the literature referenced below, dealing with the

classification of toxicants, never was less than 50 mg/kg considered

moderately toxic. In EPA's TSCA criteria for acute toxicity, 50 to 500 mg/kg
is classified as "very toxic" as is one of the systems described by Hodge and
Sterner (1949) and Gleason (1969).

The critical levels describing "highly toxic" for oral, dermal, and

aquatic LC505 are adapted from Battelle Memorial Institute, National Academy

of Sciences, State of California List of Toxic Substances, Federal Water

Pollution Control Agency, Pesticides-Title 40, Department of Transportation
Title 49, Consumer Product Safety Commission, and the Federal Hazardous
Substances Labeling Act Title 15 classifications, as well as systems presented
by Hodge and Sterner (1949). Levels of "moderate," "slightly" and "relatively
nontoxic are adapted from the National Academy of Sciences, and Hodge and
Sterner (1949).
Data available for each category for each type of exposure (i.e., oral,

dermal, aquatic) is scored independently. The score assigned to the acute
toxicity factor is the highest score given to any individual category. For

example, a chemical substance which has an oral L050 of 5-50 mg/kg, a dermal
LD5Q of 200 500 mg/kg, and an aquatic 96 hour LC50 of less than 1 mg/kg is
a551gned a score of seven, based on the extreme aquatic toxicity.
References

Cassarett, L. J.; Doull, Jr., Toxicology, The Basic Science of Poisons;

Macmillan Publishing Co., Inc., New York, 1975.

.
Gleason, M. N.; Gosselin, R.E.; Hodge, H.C.; and Smith, P.R.; Clinical
e,
Baltimor
Co.,
Toxicology of Commercial Products, 4th Ed., Williams & Wilkins

1977.

Hodge, H.C. and Sterner, S.H., Tabulation of Toxicity Classes, AIHA Quarterly
10:93-96, 1949.
Kohen, A.M., A Summary of Hazardous Substance Classification Systems (SW-171).
U.S. EPA, 1975.
U.S. EPA, Initial Report of the TSCA Interagency TestinggCommittee to the
Administrator, Environmental Protection Agency, Jan. 1978.

I(A) Potency:
Criterion:
Weighting Factor
X2
X1

Strong
Weak

This factor is applied in all categories other than acute toxicity.
Rationale:

Except in the acute toxicity category, the concept of dose to produce a
stated effect is absent in the foregoing scoring system. However, it is
recognized that materials do vary in their potency and that very potent

.

substances create greater concern and demand priority consideration over less

potent materials that may evoke the development of similar qualitative effects
but only after much higher does have reached the target cells, organs or
organisms, and often only after longer periods of time.
To account for differences in potency, the rating accorded a substance
under any toxicity
categoryis doubled if the material is judged to possess
strong potency.
The distinction between "strong" and "weak" potency with respect to
carcinogens has been maintained for many years. Weak carcinogens are those
which manifest their effects only after repeated dosage over a long period of
time, often at doses which produce other tissue damage or which induce other

effects such as altered metabolic processes. Strong carcinogens, on the other
hand, induce neoplasia with much lower doses, sometimes even with a single
exposure; latent periods may be shorter and the carcinogenic response is
frequently evoked without other concomitant pathological change.
II. CARCINOGENICITY
Criterion:
Score
4

Category
The chemical has been demonstrated to be a human positive
carcinogen (defined in (a) below) by the oral, dermal or
inhalation route of exposure.

2

The chemical has been demonstrated to be a suspected carcinogen
(defined in (c) below) by the oral, dermal, or inhalation route
of exposure.

1

The chemical has been demonstrated by accepted mutagenicity
screening tests or accepted cell transformation studies to be a
potential carcinogen (defined in (d)).

0

The chemical has been tested by the above systems and has not
been demonstrated to cause cancer or to be a potential

8

a

carcinogen.
*

Insufficient information available.

Rationale:

Most cancers are believed to be caused by exposure to extrinsic factors,
among which chemical agents are thought to be a major contributor. These
agents must be identified, evaluated,

and controlled if the incidence of

cancer is to be reduced. The committee recognizes the need to protect the
public and the environment from chemical carcinogenic hazards and their
effects. In an effort to meet this need, the above carcinogenicity criterion
was developed.

It is essential that the procedures used to determine a chemical's
carcinogenicity potential be established on the best scientific basis as is
practically possible. For the purpose of classification, chemicals will be
placed in categories relating to carcinogenic effects. If insufficient
information is available to classify a chemical, it will be so noted. The
chemical can be reclassified in an appropriate category when additional data
become available.

The catagories of carcinogenic effects are defined as follows:
(a)

Human Carcinogen

0
(b)

Positive Animal Carcinogen

0

(c)

(d)

Chemical which has been demonstrated by epidemiological and/or
clinical studies to cause cancer in man.

Chemical which has been found and confirmed to be carcinogenic

in animals.
below.)

(If observation has been made only in mice, see (c)

Suspected Animal Carcinogen
a

Chemical which has been found to be carcinogenic in one series
of well designed experiments and found to be non-carcinogenic in
repeated experiments, but no explanation is apparent to account
for the discrepancies between positive and negative results.

0

Chemical which has been found to be carcinogenic in mouse only
but not confirmed in another species.

Positive in Vitro Test Carcinogen

0

Chemical which has been found by mutagenicity tests (with or
without enzyme activation) to demonstrate carcinogenic
potential.

0

III.
IV.

Chemical which has been shown to transform normal human or
normal mammalian cells into tumour cells in replicated tests
designed to demonstrate carcinogenic potential.

REPRODUCTIVE,
HERITABLE MUTAGENICITY
(i.e., teratogenicity and foetal toxicology)
1.

teratogenic effects.

2.

foetal toxicity.

3.

embryotoxicity.

pathology, behaviour

.

Criterion:
Score
4
2
1
0
*
V.

Category
Confirmed teratogen
Suspect teratogen in multicellular organisms
Suspect mutagen in microorganisms
Not demonstrated to be a mutagen
Insufficient information

NEUROBEHAVIORAL TOXICOLOGY
Criterion:

Neurotoxicity and the potential of a chemical to cause behavioral changes
in mammals or other animals will be assessed according to the following scores:
Score
4
3
1
0
*

Category
Confirmed human neurotoxic chemical
Confirmed animal neurotoxic agent, therefore suspect in humans
Suspect animal neurotoxic chemical
No neurotoxic activity
No information

Rationale:
Score
4

Category
Chemicals known to cause nervous system malfunctions and/or
pathology, behavioral disorders including learning disabilities
in humans, will be considered as confirmed neurotoxic agents for
humans.

3

Chemicals causing neuropathies in experimental animals will
considered suspect neurotoxic agents for humans.

1

Chemicals shown to cause only behavioral changes in animals will
be considered potentially suspect neurotoxic agents for animals.

10

be

,

A chemical, adequately tested for neurobehavioral toxicity with
negative findings will be considered inactive as a neurotoxic
agent.

*

Where insufficient information is available testing should be
considered.

Score

Category
Confirmed human neurotoxic chemical
Confirmed animal neurotoxic agent, therefore suspect in humans
Suspect animal neurotoxic chemical

*OI

w-h

0

No neurotoxic activity
No information

VI. CHRONIC ADVERSE EFFECTS
Introduction and Rationale:

The category "Chronic Adverse Effects" contains a large variety of toxic
effects on a variety of target organs and tissue. Some have been left out
because they were considered unlikely to be affected by chemicals in the water
of the Great Lakes. Wherever possible however the systems are included and
scores proposed with occasional examples, which may be deleted.
The wording is usually too short and thus unclear. When effects are
observed they are adverse irreversible effects unless otherwise stated. When
effects are not observed in humans, but only in animals, it does not mean that
the effects were lacking in humans exposed to the chemicals, but rather that
humans were not exposed to the chemicals. Human data are obtained from
epidemiological studies and not from clinical reports only, which may be
erroneous in the association proposed.

When no adverse effects are observed it means that no serious adverse
effects are found. Weight loss can always be produced with a high enough dose
with any choice of chemical, but that is not meant here.
No attention was paid to genetic weakness of human populations, although
the means to do so exist. However, in experiments on animals it has
frequently been the custom to choose a strain that would display genetic
susceptibilities in order to exaggerate the effect. Although this is
permissible it should be recognized as such and given a particular
recognition, since extrapolation to the normal human population would be
impossible or difficult.
Criterion:

(a)

NO)

Score

Sense Organs
Category
N.B. Unless specified the effects are irreversible and/or
progressive
Effects observed in humans (e.g., cataracts)

Effects not observed in humans, but on experiments in animals

11

1
0
*

Reversible effects observed in humans or animals
No adverse effects observed
No information

Some effects of chemicals may be caused by interference with nerve
function or toxicity to the nerve itself and will be classified under category
V.

(b)

Score
3
2
1
0
*

Hepatobiliary System

Category
(e.g, cirrhosis, bileduct
humans
in
observed
Effects
hyperplasia)
Effects not observed in humans, but in animal experiments
Reversible effects observed in humans or animals (e.g.,
bilirubinemia)
No adverse effects observed
No information

Reversible effects should be distinguished from effects which may also be
reversible because, after the necrotic episode is over, regeneration can
replace the lost tissue.
(c)
Score
3

2
1

0
*

Urinary System
Effects in humans

Category

Effects not observed in humans, but in animal experiments
Reversible effects in humans or animals
No effects observed
No information

It is suggested including in these categories adverse effects observed, as for
instance, with NTA which produced tubular damage to the kidney at relatively
low levels and which produced renal cancers at very high dose levels which
would also be reported of course under category II.
(d)
Score
3
2

1

0
*

Cardio vascular system
Category
Effects observed in humans

Effects not observed in humans, but in animal experiments

Reversible effects observed in humans or animals
No effects observed
No information

A weighting factor of 2x is proposed for the adverse effects of this
chemical if the impaired health (due to other causes) will considerably
aggravate the toxicity of the chemical. The same consideration applies to the
respiratory system and the lymphatic system.

12

1
,

(e)

Respiratory System

Score

Category

3

Effects observed in humans

Effects not observed in humans, but in animals in experiments

2

Reversible effects observed in humans or animals
No effects observed
No information

1
0
*

A weighting factor of 2x is proposed here also even though the
contribution of chemicals via the Great Lakes to the respiratory system may be
rare or unlikely. The conditions of impaired health may include emphysema,
edema, fibrosis, etc.

(f)

Blood Forming System

Score
3
2
1
0

Category
Effects in humans, e.g., porphyrias
Effects not observed in humans, but in animal experiments
Reversible effects in humans or animals
No effects observed

*

(9)

No information

Lymphatic System

Score
3
2

1

0
*
(h)

Score
3
2
1
0
*

Category
immunopathology
e.g.,
humans,
Effects in

Effects not observed in humans, but in animal experiments

Reversible effects in humans or animals including chromosomal
abnormalities
No effects observed
No information
Endocrine System

Category
Effects in humans
Effects not observed in humans but in experimental animals
Reversible effects in humans or animals
No effects observed
No information

This subcategory should include adverseeffects on the hypothalamus and
the pituitary gland as well as the endocrine organs under pituitary control
and target organs under the influence of specific hormones. The subcategory
may also have to contain the effects of chemicals secreted by the mammary
gland and affecting the young offspring.

(i)
Score
3
2
1

Reproductive System
Category
Effects in humans, e.g., sterility
Effects not observed in humans but in experimental animals
Reversible effects observed in humans or animals

13

0
*

No effect observed
No information

This category may also contain the effects of chemicals binding to
encephalin-receptors, e.g., potential loss of libido

(j)

Gastro-Intestional System

Score

Category

3
2
1

Effects observed in humans
Effects not observed in humans, but experimental animals
Reversible effects in humans or animals

*

No information

0

No effects observed

I

A weighting factor of 2x may have to be applied in this subcategory
because impairment of normal function may lead to aggravated responses to
chemicals entering the 6.1. tract.
(k)
Score

Skin
Category

2

Effects observed in humans

0
*

irreversible
No effects observed
No information

1

Effects observed in animals which may be reversible or

A weighting factor of 2x may be applicable under conditions of impairment
producing abnormal absorption of chemicals or aggravation of effect.
The committee is currently evaluating the 400 compounds identified in the

Water Quality Board's report (193. gig) utilizing the above categories of
criteria and scoring systems.
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ESTIMATES OF HUMAN EXPOSURE
FROM ENVIRONMENTAL DATA

Possible health effects of Great Lakes water quality from any chemical
compound or agent are a function of both the toxic (carcinogenic) properties
of the compound and the possible exposure of man to it.
In order to be concerned about a compound, we consider exposure of any
identifiable group of people, however small, and in any area in the Great
Lakes Basin, however limited in size.
Exposure is determined by:
1.

Inputs into the Great Lakes and the resulting concentrations in the
several compartments of the Great Lakes ecosystem.

2.

Rates of transformation and translocation within'and between compartments.

3.

Intake by man of water or food from these compartments.

Beginning with

point (3) we identify the following target populations:

(a)

Any local population deriving their drinking water from the Great
Lakes.

(b)

Any local population deriving a substantial portion of their total

(c)

Any local population consuming waterfowl (hunters and their families).

(d)

Any local population deriving a significant portion of their food
from land irrigated with Great Lakes water or from livestock drinking
Great Lakes water.

food intake from Great Lakes fish.

The following additional target populations are recognized as part of the
greater ecosystem of the Great Lakes but are excluded from considerations of
Great Lakes water quality.

(e)
(f)

Local populations deriving food from land receiving wastewater

sludges.

Populations exposed in the occupational, domestic, and urban

environment to contaminants identified in Great Lakes water and
traceable to land sources.

Exposures from (e) to (f) must be taken into account also in determining
total exposure of a local population to the contaminant.
Input and concentration data are the points of departure for estimates of
exposure. They are shown in boxes in Figure 1, below. Input data are

15
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available from measurements of concentrations and flows, or from estimates of

production, use, and loss of chemicals.

Input data are related to

concentration data by factors such as dilution, partition, chemical or

microbial degradation, bioaccumulation, etc., (marked by arrows in Figure 1).
For some compounds, the data base available involves numerous measurements

5,

of the compounds in several compartments over a large part of the Great Lakes

Basin. For other compounds, data are sparse and are available only for
limited areas and few, or one compartment of the ecosystem.
For the areas
known to show measurable concentrations of the compounds, order-of-magnitude
estimates of concentrations in other compartments in the same area can be made

by applying conversion factors on dilution, partition, degradation, and
bioaccumulation. Extrapolation to other areas in the basin is difficult and
would be based on known patterns of production and use of chemicals,
generalizations on likely sources, etc. In order to undertake this effort,
the group recommends the reworking of the available data base (Great Lakes
Water Quality Board - Appendix E, Status Report on Organic and Heavy Metal
Contaminants in the Lakes Erie, Michigan, Huron and Superior Basins, IJC,
Windsor, Ontario, July 1978) into a more useful format giving for each
compound, the available data by geographic location and by compartment (amount
discharged or effluent concentration measured, concentration in sludge,

concentration in water, concentration in sediment, concentration in fish,
concentration in other biota). This information will then be analyzed by the
above procedures to derive estimates of exposure for any of the possible
target populations.
This estimate of the exposure together with data on toxicity, including
factors such as carcinogenicity, persistence in man, etc., for each compound
will produce a measure of concern by the committee for public health effects
from any given compound, refined as is possible by estimates of synergistic
and other interactions among compounds.
If effect levels are known for a

compound, the ratio of exposure level to effect level is a measurement of the

public health concern.

17

The IogicaI sequence of this procedure is sumnarized in Figure 2, beIow.
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INTERACTIONS IN TOXICOLOGY:
AN OVERVIEW

Interactions in drugs as suggested in the translation of the Papyrus Ebers

is an ancient interest (Rossi,

'63).

The course of history of interactions in

toxicology would run parallel to that for drugs since no drug is free of toxic
effects (Fingl and Woodbury, '70). Accumulated knowledge of drug
interactions, however, is much greater than interactions in toxicology (James,
£5 31., '78). This latter statement would be expected when one considers the
age difference between these two sciences. Man, not necessarily man the
scientist, has been interested for centuries in the basic effect of a poison.
How it worked, or interacted, was not his concern as long as the measured
effect, death, was

achieved. From that simple observation of yesterday,

scientists today are turning more earnestly to the

the causes" (Rothman, '76).

question of interaction of

Interactions in toxicology are no longer viewed as a basic biochemical
event but they are recognized as complex, complicated and controversial.

Assessment of a toxicant is interrelated to nutrition, stress, age, sex,
genetics, prior or concurrent diseases, body weight, route of administration,

its pharmacokinetics and the environment. With so many diverse factors
affecting the observed effect the underlying mechanism becomes very difficult
to solve or understand (i.e., complicated). Controversies will undoubtedly
arise because most interactions in toxicology have not been resolved.

Foremost among these controversies are the problems of interactions with
minute or large dosages of a chemical carcinogen (Maugh, '78). The task of
this overview is to look at interactions in toxicology, excluding drug
toxicology. Drug toxicology cannot be completely forgotten because many of
the terms and ideas of interactions in pharmacology have entered toxicology.
This presentation contains a brief outline of interactions; its definition,

types and controversies. The basic intention is that of an outline. Models
and approaches to assessing interactions in toxicology are also present.
Definition
The word interaction is too often used in a facile manner to confer an

understanding of a sequence of biochemical events for which little or nothing
is known. It is used to bridge the veiled gap between (i.e., inter-) cause
and effect. An illusion is presented, analogous to the use of the word
evolution, that the measured effect can be attributed to an interaction.

Yet,

no explanation is given to or is known of the series of biochemical events
which comprise the interaction. The truth in most instances is that we do not

know, as yet, the mechanisms of interactions. A discussion of interactions,
more often than not, describes the measured effect with little reference to

the causal mechanism.

Death is the easiest measured effect of an interaction. To gain an
appreciation of the potency (i.e., toxicity) with which the interaction has

ensued, toxicologists have devised the L050.

The measurement of the

dose response relationship can be derived for a given toxicant by several
19

models, for instance, the method of Miller and Tainter ('44), Litchfield and
Wilcoxon ('49), and Neil ('52). A standard protocol for deriving the LD50
was established as a further assurance that the estimated value of a tox1cant
can be obtained in all laboratories (Fed. Reg.). Changes in the L050 are
used as an interaction indicator (Magos, '74).
Tests in toxicology, such as acute, chronic, reproductive and
teratological, provide a direct measurement of the effect of the interaction

but nothing is contributed towards the mechanism of the interaction, p§r_§g.

The greatest contribution towards understanding interactions has come with
the application of kinetics to a toxicant. Principally developed for use in
clinical evaluation and use of drugs (Levy and Gibaldi, '75), the science of
pharmacokinetics is providing a much needed stimulus in toxicology (Gehring,

et al. '76).

Information on the absorption, distribution, metabolism and

excretion of a chemical is derived by a time plot of the data which is then
applied to compartmental open models.
Results from the battery of toxicological tests and pharmacokinetics are
obtained under controlled experimental conditions in which all possible
parameters (i.e., temperature, humidity, stress, dose, nutrition, etc.) are

regulated. The desire is understandable because without eliminating or
controlling the many variables, agreement on the action of a toxicant would
never be achieved. However, information derived with maximum control is not
the real life situation for, in reality, the controls are reduced and the
Interactions, especially interactions of
toxicants becomemultiples.
toxicants in combination, must be considered in their complexity (Magos, '76).

Finney ('52) presented mathematical models to explain the possible
different effects obtained for joint interactions of biologically active
chemicals. The usefulness of Finney's model was tested by Smyth, et al. ('69
and '70). Pharmacology has used the Loewe, ('53) and the approach of_Chen and
Ensor ('53 and '54) to analyse effects of combined drug interactions. Both of
these sciences, toxicology and pharmacology, use the same terms to describe
interactions and unfortunately have carried on some disagreement about the
meaning of the terms " synergism", "potentiation", "sensitization" but with
more agreement on the terms additive, antagonistic and independent.
Types of Interactions

The confusion surrounding synergism to describe an effect of an
interaction is another example arising from a lack of understanding of the
mechanics of interactions. Some authors use "the end-effect of the
combination as a measure of comparison while others used the individual
activities of the compounds" (Veldstra, '56). Others adhere to the
epistemological meaning.
Synergism (GK. synergos) literary means working together", "cooperation"
(Rossi, '63 and Sunier, '72). Synergism in toxicology is generally accepted
as being similar to that definition used in pharmacology; "the cooperative
action of discrete agents, such that the total effect is greater than the sum
of the two effects taken independently" (Veldstra, '56) and that adopted for
epidemiology where the risk attributable to a combined exposure exceeds the

sum of the risks attributable to each exposure separately" (Rothman, '74).
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Magos ('74), however, considers that when "the action can be greater than the

algebraic summation" it is supplemental synergism or potentiation. He also
uses the term "additive synergism" as the simple algebraic sum. Veldstra
('56) argues against the use of the term potentiation.

Interactions which produce synergistic effects are not an exception but a
common occurrence. Some food additives have a synergistic toxic effect when
incorporated in a purified, low fiber, diet (Ershoff, '76). Herbicides can
increase the toxicity of insecticides to potencies greater than either given
alone (Lichtenstein, e: 31. '73). Methylmercury in combination with nitrite
and ethylurea reduced survival of progeny (Nixon,

'77).

Combinations of

aflatoxin B, and Fusarium toxic, T Z, produced a synergistic lethal response

(Lindenfelser, gt g1. '74).

The herbicide silvex is degraded by the

synergistic action of aquatic microorganisms (Ou and Sikka, '77). Hicks and
Chowaniec ('77) studied the importance of synergy between weak carcinogens and
bladder tumours.
Veldstra ('56) states that the term "potentiate" should be discontinued
because it means "to endow with power" and in combination the resident
"power," viz. specific activity, is not altered but "the effectiveness of the
power already present is enhanced." Fingl and Woodbury ('70) agree with
Veldstra that potentiation should be abandoned. Rossi ('63) notes that
Webster's dictionary provides some justification for its use; potentiate - "to
make potent or more effective." Scientists may be using "potentiate" in the
same sense that it is employed in physics, that is, energy which is involved
because of position or condition. Magos ('74) defines potentiation, also
called supplemental synergism, as an action greater than the algebraic
summation. The latter definition is the same as that given to synergism.
Enhancement of a response by a combination of an active and an inactive
compound has also been designated as sensitization (Rossi, '63). Finally,
there is the often cited "synergistic" interaction of EPN and malathion
although the authors referred to this interaction as a "potentiation"
(Frawley, gt_al. '57).

Although there is some confusion about the meaning or use of potentiation,
this has not impeded the publication of papers. Isopropyl alcohol and acetone
potentiated the hepatotoxicity in rats of chlorinated hydrocarbons (Traiger
and Plaa, '74). The chlorinated hydrocarbon, carbon tetrachloride was
potentiated in rats by sodium nitrite (Suarex and Bhonsle, '74). Lead
chloride and lead nitrate increased mortality in mice by enhancement of
encephalitogenic potential of Langat virus (Thind & Singh,

'77).

Murphy

reported the potentiation of toxicity of the anesthetic fluroxene by
polychlorinated biphenyls.

Antagonistic interactions which eliminate an undesirable effect are the
most beneficial to man. This happens when the combined effects are less than
that of the active component alone. An antagonistic effect is reported for
riboflavin and hepatoma induction by an azo dye (Lambooy, '76). Rats
pretreated with aldrin are protected against the toxicity of parathion
(Kinoshita, '74). Selenium protects against cadmium and mercury toxicity
(Parizek, '76).
There is no shortage of models (i.e., procedures to be followed or

emulated) to determine the effects of the various interactions, however, there
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are few models that explain the interactions.

The models for deriving the

L050 and those of pharmacokinetics have been discussed.

Runner ('67)

presented models to explain the various effects (e.g., synergistic,
antagonistic) for concomitant teratogenic treatment. Problems of synergism
and antagonism in epidemiology are discussed by Rothman ('74 and '76). Last

and Cross ('78) presented a model for assessing biological effects of

atmospheric pollutants on the respiratory tract, mucus-producing apparatus. A
method was proposed by Carlson and Bazzaz ('77) to quantitate the concept of
synergism in plants. A model to test the effect of exposure to a subtoxic
challenge upon cellular integrity is described by Chin, gt_al. ('78). A
bioassay was reported for detecting both synergistis and antagonists of
paraoxon and malaoxon (Cohen and Murphy, '73).
Controversies
Undoubtedly, the most controversial subject of interactions is in chemical

carcinogens. The arguments indicate how little is known about interactions at
very low dosages (Maugh, '78). There presently exist two schools of thought;
"one hit" hypothesis or single event and "threshold" hypothesis, or no-effect
level. The former believe basically that cancer results from the interactions
of one molecule of a carcinogen with a critical receptor in one cell. Models
such as the probit and Mantel-Bryan extrapolations are used in this case. The
other school states that there is a no-effect dose for a chemical carcinogen
governed by a series of pharmacokinetic interactions before reacting with
DNA. Gehring ('76) has demonstrated that the pharmacokinetics do change with
different doses of a carcinogen.
v
Toxicological tests also deviate toward "larger than life" dosages and in
so doing create a controversy over the use of super dosages. One side argues
that we must obtain as much knowledge as possible about the undesirable
effects of a toxicant. The other side states that these are zealous
platitudes which are not the real life situations and the acquired knowledge
is often misused.

Interactions in teratology and mutagenicity tests are not without their
controversies. Do the same interactions which culiminate in birth defects in
polytocous animals exist in man? Were not the doses given absurd? The

emphasis, today, is that a chemical is, "teratogenic in the [at . . . . . . or the
mouse . . . . . . or the rabbit", clearly indicating that it has not been

demonstrated so in man. Similarly, the problem of extrapolating the results
of mutagenicity tests to a multicellular organism.
Conclusions

It is inherent that the use of "overview" in the title of this paper will
result in other aspects of interactions being overviewed. The most evident is
a citation of mechanisms of interaction that are known.
Dubois, et al. ('68) provided the explanation for the synergistic effect
between EPN and Malathion. This original observation had led to an
understanding of the biochemical mode of action of pesticides (Corbett '74 and
Wilkinson, '71 and '76). Some insight into the mechanism of carcinogenesis
has been achieved. It is now thought to be a two-stage event which requires,
firstly, an initiator and then a promoter (Miller, '78). Conney and Burns,
22

('72) reported other possible mechanisms of interaction for insecticides.
Mechanisms of interaction, briefly presented in the preceding paragraph,
have not completely eluded research, however; they are complex, complicated
and controversial.
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Adr. Environ. Sci. Technol.

photomirex is 10 100 times more toxic than mirex and 5 times more toxic than
kepone. In rat feeding studies, photomirex was observed to produce lesions in
the testes, thyroid and liver of male rats. Subsequent experiments have shown
that this compound causes ultrastructural alterations in the liver and testes
at extremely low levels, and that the alterations persist for up to a year
after photomirex exposure has ceased. Like its parent compound mirex,
photomirex is also able to produce cataracts in suckling rats whose mothers
are exposed to the compound. Metabolism and pharmacokinetic data have shown
that photomirex is not metabolized in rats to any significant degree, and is
not excreted in the bile. The main excretory route is through the feces.
Conclusions

The data presented at the meeting on photomirex indicate that this compound
could have greater potential as a human health hazard than mirex. This
example serves to indicate that Great Lakes Monitoring and Surveillance
Programs should be designed not only to provide data on parent compounds, but
also on their degradation products.
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LEAD
In its Final Report, PLUARG drew attention to its concern over the build
up of lead in sediments, particularly in Lakes Erie and Ontario. Studies
undertaken by PLUARG suggest that non-point sources are by far the greatest
component of the load.
Concern over lead at this time arises not from any evidence that current
levels of lead in drinking water or fish tissues exceed health-based
regulatory standards, but because of recent evidence that inorganic lead in
sediments may be transformed into more toxic organic forms by biological
mechanisms in Great Lakes sediments.
The major diffuse source of lead in the Great Lakes Basin is the
automobile. Alkyl lead compounds have been extensively used to improve the
combustion characteristics of gasoline. When burned in the gasoline engine,
most lead in gasoline is converted into inorganic form and emitted as halides
which subsequently are converted during aging to oxides, sulphates and
carbonates. In these compounds, lead is in particulate form and settles over
the landscape as dust. Lead from automobile exhausts enters the aquatic
system primarily in surface run-off although a small proportion undoubtedly
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enters the lakes through atmospheric fallout and precipitation.
In 1975-76, three different groups of scientists (including one from the
Canada Centre for Inland Waters, the others being in the United Kingdom and in
Germany) reported that micro-organisms can methylate organic and inorganic
lead compoundsl-3. By analogy with mercury, the Comnittee had concern that
the existence of methylated lead in the environment could lead to the
recognition of hitherto unsuspected toxic effects.
The Committee reviewed the evidence relating to biomethylation of lead in
the aqueous environment. It noted a recent report of the World Health
Organization's Task Group on Environmental Health Criteria for Lead which
concludes that:
"Acute toxicity results in an encephalopathy that differs
greatly from the effects of inorganic lead on the central
nervous system.

Some components of the toxic effect are

probably due to the alkyl compound as a whole rather than
its lead components.
The Comnittee concluded that the substrates, conditions and mechanisms

which may lead to alkylation of lead in the environment are not known at the

present time, and it recognizes the need for improvements in analytical
methods and quality control procedures. Nevertheless, it considers that there
is a need for exploratory measurements to be made to determine whether
alkylated lead compounds are present in sediments, algae, invertebrates, fish

and wildlife from the Great Lakes, and, if so, in what form and in what
concentration. The Committee is willing to evaluate such data with a view to
elucidating the possible health effects in order to determine whether present
tolerances for lead; especially in fish, need re-evaluation. The Committee
requests the Water Quality Board and the Research Advisory Board to encourage
the gathering and publication of such data in conjunction with on-going
monitoring efforts and to bring emerging information and analytical data to
its attention.
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@RECOMMENDATIONS

During 1978, the committee proposed to both Boards, the following
activities for inclusion in the IJC Regional Office program budget.

1.

A Study on Intervention Guidelines for Great Lakes Environmental
Contaminants in Fish
A survey would be made of the appropriate regulatory agencies in the
Great Lakes Basin to determine and document the philosophy underlying
the rationale used in setting standards for individual environmental
contaminants in fish.
The assignment would be contracted to an individual familiar with the
regulatory agencies concerned and with their appropriate
representatives, at all levels of government affecting the Great
Lakes. Hence, a period of extensive travelling would be anticipated
by the consultant.
The study would aid in clarifying cases of diSparity among different
agencies by delineating and comparing the criteria used in deriving
their standards.

Estimated cost of this study - $10,000 (FY 79/80).
A Workshop on the Interaction of Toxic Chemicals of Concern in the

Great Lakes Ecosystem

$15,000 (FY 80/81)

Models are currently under development to evaluate the toxicity of
exposure to mixtures and verification of the models is necessary for
predicting the combined effects of the compounds present. Based on
acute toxicity data for the individual chemicals, prediction of their
joint action has been possible but is presently limited to handling
two or three interacting compounds at one time.
The workshop is intended to review the current state of knowledge
concerning these predictive models, the nature of their data
requirements,

and the limitations of their application.

In addition,

the results of this activity will complement the Water Quality
Board's list of chemicals found in the Great Lake ecosystem and will
aid in the process of identifying and quantifying potential
toxicological effects of interactions.
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